Maternal Deltamethrin Exposure Triggers p53-Mediated Ferroptosis and Cognitive Deficits in Offspring

Study Background and Research Question

Deltamethrin (DM) is a widely used type II pyrethroid insecticide, well-known for its neurotoxic potential due to its ability to cross the blood-brain barrier and disrupt nervous system function. While environmental and occupational exposures to DM are common, concerns have grown regarding its impact on early neurodevelopment, particularly when exposure occurs during critical windows such as gestation and lactation. Prior studies have implicated DM in oxidative stress, iron metabolism disruption, and cognitive impairment, but the precise cell death mechanisms and signaling pathways mediating these effects remain insufficiently clarified.

The reference study (Huang et al., 2025) sought to address whether prenatal and early postnatal DM exposure impairs hippocampal learning and memory in male offspring through ferroptosis, a form of regulated cell death characterized by iron-dependent lipid peroxidation, and to elucidate the involvement of the p53 pathway in this process.

Key Innovation from the Reference Study

The core innovation of this research lies in its mechanistic dissection of how maternal DM exposure induces ferroptosis in the developing hippocampus via a p53-dependent axis, establishing a direct link between environmental toxicant exposure, neuronal ferroptosis, and cognitive dysfunction. The authors demonstrate that the p53-regulated SLC7A11/GPX4 pathway is critical for mediating DM-induced ferroptosis, providing a targetable molecular mechanism for potential neuroprotection strategies.

Additionally, the study explores the downstream activation of the phospholipase C (PL-C)/inositol triphosphate receptor (IP3R) signaling pathway and subsequent calcium dyshomeostasis in the hippocampus, extending the mechanistic chain from ferroptosis to neuronal signaling disruption and cognitive impairment.

Methods and Experimental Design Insights

The investigators employed a combined in vivo and in vitro approach:

• Animal Model: Pregnant Wistar rats were randomly assigned to four groups and orally administered 0, 1, 4, or 10 mg/kg/day DM from gestational day 0 to postnatal day 21.
• Behavioral Analysis: Offspring underwent T-maze and shuttle box passive avoidance tests to assess hippocampal-dependent learning and memory. Nissl staining quantified neuronal survival in the hippocampus.
• Biochemical Assays: The researchers measured hippocampal levels of ferrous ion, glutathione (GSH), malondialdehyde (MDA), and prostaglandin-endoperoxide synthase 2 (PTGS2) protein. Expression of key ferroptosis-related proteins (SLC7A11, GPX4), and p53 was evaluated.
• Signaling Pathway Analysis: The activation of the PL-C/IP3R pathway and changes in intracellular Ca²⁺ and calcineurin (CaN) levels were determined.
• Cell Culture Experiments: HT-22 neuronal cells were exposed to DM in vitro, with intervention by ferrostatin-1 (a ferroptosis inhibitor) and Pifithrin-α (PFTα) to dissect the role of p53-mediated ferroptosis.

This multifaceted design allowed the authors to correlate behavioral outcomes with molecular and cellular events, and to use specific inhibitors to confirm causality.

Core Findings and Why They Matter

Key findings from the study include:

• Cognitive Impairment: Male offspring of DM-exposed dams showed reduced T-maze performance and increased passive avoidance rates, indicating learning and memory deficits (Huang et al., 2025).
• Hippocampal Neuronal Loss: Nissl staining revealed a dose-dependent reduction in hippocampal neuron numbers in DM-exposed groups.
• Ferroptosis Markers: DM exposure increased hippocampal ferrous ion, MDA, and PTGS2, while depleting GSH—hallmarks of ferroptosis. Protein analysis confirmed decreased SLC7A11 and GPX4, with elevated p53 expression.
• p53 Dependency: In vitro, both ferrostatin-1 and Pifithrin-α ameliorated DM-induced ferroptosis and neuronal death, highlighting the centrality of p53 in mediating this process.
• Calcium Signaling Disruption: DM-enhanced ferroptosis activated the PL-C/IP3R pathway, increased intracellular Ca²⁺ and CaN, leading to calcium imbalance—a known contributor to synaptic dysfunction and cognitive impairment.

These results establish a mechanistic framework whereby maternal DM exposure impairs offspring cognition through p53-driven ferroptosis and secondary calcium signaling disruption. The study provides compelling evidence that interventions targeting p53 or ferroptosis may mitigate neurodevelopmental toxicity from environmental exposures.

Comparison with Existing Internal Articles

A body of internal literature corroborates and extends these findings:

• The article "Maternal Deltamethrin Induces p53-Mediated Ferroptosis in Offspring" provides additional context on the neurodevelopmental risks of prenatal DM exposure, emphasizing the role of p53 in iron-dependent neuronal loss and establishing the translational relevance for risk assessment.
• "Pifithrin-α: Advanced Protocols for p53 Inhibition in Neurotoxicity" details the application of PFTα in dissecting p53-dependent cell death mechanisms, offering actionable guidance for workflow design in both neurotoxicity and radioprotection models. This complements the reference study's use of PFTα to specifically inhibit p53-mediated ferroptosis in neuronal cells.
• The systems-level review "Pifithrin-α (PFTα): Integrative Approaches to p53 Inhibit..." discusses the broader implications of p53 inhibition across apoptosis and ferroptosis research, positioning PFTα as a versatile tool for mechanistic dissection in neuroprotection contexts.

Together, these resources underscore the growing consensus on the importance of p53 in mediating environmentally induced ferroptotic neuronal loss and highlight PFTα as a valuable research tool for pathway interrogation.

Limitations and Transferability

Despite the robust experimental design, several limitations warrant consideration:

• Species Differences: The primary data are derived from rat models and HT-22 neuronal cell lines, which may not fully recapitulate human neurodevelopmental responses.
• Sex-Specific Effects: This study focused on male offspring; the extent to which findings generalize to females remains to be determined, given known sex differences in neurotoxic susceptibility.
• Exposure Paradigms: The oral dosing and exposure window are relevant for high-risk populations but may differ from typical environmental exposures in humans.
• Complexity of p53 Signaling: While p53-mediated ferroptosis is clearly implicated, p53 also regulates multiple cell death and survival pathways, and off-target effects of inhibitors such as PFTα should be considered in translational applications.

Nevertheless, the integration of behavioral, cellular, and molecular data enhances the mechanistic credibility of the findings and suggests a reasonable degree of transferability to mammalian neurodevelopmental risk assessment frameworks.

Protocol Parameters

• DM Exposure: Pregnant rats: 0, 1, 4, or 10 mg/kg/day by oral gavage from gestational day 0 to postnatal day 21; aligns with established neurotoxicity protocols.
• Behavioral Assessment: T-maze and shuttle box passive avoidance for hippocampal-dependent cognition; Nissl staining for neuron quantification on postnatal day 21.
• Cellular Interventions: HT-22 cells treated with DM in vitro; pre-incubation with ferrostatin-1 (ferroptosis inhibitor) or Pifithrin-α (p53 inhibitor) at literature-supported concentrations before DM application to assess pathway involvement.
• Biomarker Analysis: Quantification of ferrous ion, GSH, MDA, PTGS2, SLC7A11, GPX4, p53, Ca²⁺, and CaN via standard biochemical and immunoblotting techniques.

Research Support Resources

Researchers aiming to replicate or extend these workflows can utilize Pifithrin-α (PFTα) (SKU A4206) as a precise, chemical p53 inhibitor to dissect p53-dependent apoptosis inhibition and ferroptosis in neuronal models. According to the product information, PFTα is water-insoluble but dissolves effectively in DMSO or ethanol and should be stored at −20°C as a solid for optimal stability. APExBIO provides detailed handling protocols for experimental reproducibility. Incorporating PFTα into neurotoxicity or radioprotection workflows enables targeted investigation of p53 signaling and cell cycle arrest induction, as demonstrated in both the reference and internal studies.